Literature DB >> 22362409

Bottlenecks caused by software gaps in miRNA and RNAi research.

Sean Ekins1, Ron Shigeta, Barry A Bunin.   

Abstract

Understanding the regulation of gene expression is critical to many areas of biology while control via RNAs has found considerable interest as a tool for scientific discovery and potential therapeutic applications. For example whole genome RNA interference (RNAi) screens and whole proteome scans provide views of how the entire transcriptome or proteome responds to biological, chemical or environmental perturbations of a gene's activity. Small RNA (sRNA) or MicroRNA (miRNA) are known to regulate pathways and bind mRNA, while the function of miRNAs discovered in experimental studies is often unknown. In both cases, RNAi and miRNA require labor intensive studies to tease out their functions within gene networks. Available software to analyze relationships is currently an ad hoc and often a manual process that can take up to several hours to analyze a single candidate RNAi or miRNA. With experiments frequently highlighting tens to hundreds of candidates this represents a considerable bottleneck. We suggest there is a gap in miRNA and RNAi research caused by inadequate current software that could be improved. For example a new software application could be created that provides interactive, comprehensive target analysis that leverages past datasets to lead to statistically stronger analyses.

Mesh:

Substances:

Year:  2012        PMID: 22362409     DOI: 10.1007/s11095-012-0712-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  44 in total

1.  Implementation of an ADME enabling selection and visualization tool for drug discovery.

Authors:  Chad L Stoner; Eric Gifford; Charles Stankovic; Christopher S Lepsy; Joanne Brodfuehrer; J V N Vara Prasad; Narayanan Surendran
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534

2.  A role for Gcn5 in cardiomyocyte differentiation of rat mesenchymal stem cells.

Authors:  Li Li; Jing Zhu; Jie Tian; Xiaoyan Liu; Chuan Feng
Journal:  Mol Cell Biochem       Date:  2010-09-12       Impact factor: 3.396

Review 3.  Functional genomics to new drug targets.

Authors:  Richard Kramer; Dalia Cohen
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 4.  Increasing the robustness and validity of RNAi screens.

Authors:  Steven A Haney
Journal:  Pharmacogenomics       Date:  2007-08       Impact factor: 2.533

5.  Functional genomic analysis of the Wnt-wingless signaling pathway.

Authors:  Ramanuj DasGupta; Ajamete Kaykas; Randall T Moon; Norbert Perrimon
Journal:  Science       Date:  2005-04-07       Impact factor: 47.728

Review 6.  Future prospect of RNA interference for cancer therapies.

Authors:  Eishi Ashihara; Eri Kawata; Taira Maekawa
Journal:  Curr Drug Targets       Date:  2010-03       Impact factor: 3.465

7.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

8.  MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Authors:  Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Subramaniam Tavintharan; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

9.  siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.

Authors:  Yuki Naito; Jun Yoshimura; Shinichi Morishita; Kumiko Ui-Tei
Journal:  BMC Bioinformatics       Date:  2009-11-30       Impact factor: 3.169

10.  Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress.

Authors:  Coralia Luna; Guorong Li; Jianmimg Qiu; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2009-11-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.